|
1）Michel JB, Guettier C, Philippe M, et al. Active immunization against renin in normotensive marmoset. Proc Natl Acad Sci U S A. 1987; 84: 4346–50
|
|
|
|
2）Michel JB, Sayah S, Guettier C, et al. Physiological and immunopathological consequences of active immunization of spontaneously hypertensive and normotensive rats against murine renin. Circulation. 1990; 81: 1899–910
|
|
|
|
|
|
3）Downham M R, Auton TR, Rosul A, et al. Evaluation of two carrier protein–angiotensin I conjugate vaccines to assess their future potential to control high blood pressure (hypertension) in man. Br J Clin Pharmacol. 2003; 56: 505–12
|
|
|
|
|
|
4）Ambuhl PM, Tissot AC, Fulurija A, et al. A vaccine for hypertension based on virus-like particles: preclinical efficacy and phase 1 safety and immunogenicity. J Hypertens. 2007; 25: 63–72
|
|
|
|
|
|
5）Zhu F, Liao YH, Li LD, et al. Target organ protection from a novel angiotensin II receptor (AT1) vaccine ATR 12181 in spontaneously hypertensive rats. Cell Mol Immunol. 2006; 3: 107–14
|
|
|
|
|
|
6）Chen X, Qiu Z, Yang S, et al. Effectiveness and safety of a therapeutic vaccine against angiotensin II receptor type 1 in hypertensive animals. Hypertension. 2013; 61: 408-16
|
|
|
|
|
|
7）Nakagami F, Koriyama H, Nakagami H, et al. Decrease in blood pressure and regression of cardiovascular complications by angiotensin II vaccine in mice. PLoS One. 2013; 8: e60493
|
|
|
|
|
|
8）Ishii KJ, Kawagoe T, Koyama S, et al. TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines. Nature. 2008; 451: 725-9
|
|
|
|
|
|
9）Koriyama H, Nakagami H, Nakagami F, et al. Long-term reduction of high blood pressure by angiotensin II DNA vaccine in spontaneously hypertensive rats. Hypertension. 2015; 66: 167-74
|
|
|
|
|
|
10）Brown MJ, Coltart J, Gunewardena K, et al. Randomized double blind placebo controlled study of an angiotensin immunotherapeutic vaccine (PMD3117) in hypertensive subjects. Clin Sci (Lond). 2004; 107: 167–73
|
|
|
|
|
|
11）Tissot AC, Maurer P, Nussberger J, et al. Effect of immunizations against angiotensin II with CYT006-AngQb on ambulatory blood pressure: a double-blind, randomized, placebocontrolled phase IIa study. Lancet. 2008; 371: 821–7
|
|
|
|
|